IP Cases — 2025
1,915 decisions across all jurisdictions
Page 39 of 64 · 1,915 total
Mankind Pharma Limited v.Caremankind Hospital Private Limited
Mankind Pharma Limited successfully secured an interim injunction against Caremankind Hospital Private Limited in the Delhi High Court. The court found a prima facie case for infringement and passing off, noting that the defendant was using identical or deceptively similar marks ('MANKIND'/'CAREMANKIND') in relation to similar services. This crucial early ruling protects Mankind Pharma's established brand equity while the main suit proceeds.
Viiv Healthcare Company And Anr v.Dy Controller Of Patents And Designs And Ors.
Viiv Healthcare Company appealed a decision by the Deputy Controller rejecting its patent application (IN 3865/KOLNP/2007) for HIV integrase inhibitors Dolutegravir and Cabotegravir. The appeal challenged the rejection order, citing exceptional delays in the patent process. The court allowed the appeal, setting aside the impugned order.
Ona Patents SL v.Apple Inc., Apple Retail Germany B.V. & Co. KG, Apple Retail France EURL, Apple GmbH, Apple Distribution International Ltd.
Ona Patents SL initiated infringement proceedings against Apple Inc. and its subsidiaries concerning EP 2 263 098 B1, which included a counterclaim for revocation. In this procedural order, the Düsseldorf Local Division decided to proceed with a joint hearing of both the infringement action and the revocation counterclaim. This decision streamlines the process by ensuring that validity and infringement are assessed under a single, uniform interpretation of the patent by the same judicial panel.
Myokardia Inc. v.Lucius Pharmaceutical
Myokardia Inc. filed a suit against Lucius Pharmaceutical alleging infringement of its Indian Patent No. 392872, which covers novel pyrimidinedione compounds used to treat serious cardiovascular diseases like hypertrophic cardiomyopathy (HCM). The Plaintiffs argued that the defendants' generic product infringed upon their patented technology and caused irreparable harm. Based on a prima facie assessment, the Delhi High Court granted an ex-parte ad-interim injunction restraining the defendants from manufacturing or selling generic Mavacamten until further hearing.
KNAPP Smart Solutions GmbH v.Becton Dickinson Rowa Germany GmbH
In this procedural order, KNAPP Smart Solutions GmbH sought an extension of deadlines related to its infringement claim against Becton Dickinson Rowa Germany GmbH concerning EP 2 133 289. The court partially granted the request, setting a new deadline for various pleadings until September 5, 2025. This decision highlights the UPC's strict procedural adherence, where extensions must be calculated carefully to avoid conflicts with subsequent hearing dates and rules regarding weekend extensions.
Amgen Inc. v.Regeneron Pharmaceuticals Inc.
In a significant decision concerning patent validity in the pharmaceutical sector, the UPC Court of Appeal ruled in favor of Amgen against Regeneron. The court successfully defended the patent by affirming that the claims met the requirements for inventive step and sufficiency. Furthermore, the ruling provided detailed guidance on interpreting medical use claims, emphasizing that therapeutic efficacy is an inherent feature of such claims, not a matter to be proven solely from the claim text.
Amgen Inc. v.The Assistant Controller of Patents and Designs
Amgen Inc. appealed an order by the Assistant Controller of Patents which held that claims 1-13 of Patent Application No. 5857/CHENP/2008 were not patentable due to various sections of the Patents Act, 1970. The Madras High Court allowed the appeal, finding that the claimed invention satisfied all requirements for protection and directing that the application proceed to grant.
AMST – SYSTEMTECHNIK GMBH v.Government of India
The petitioner challenged an order treating its Patent Application No.3022/CHENP/2011 as withdrawn due to failure to request examination within the stipulated period. The court considered the sequence of events, noting that the petitioner intended to prosecute the application and citing previous judgments where similar facts led to non-withdrawal.
Pureplay Skin Sciences (India) Pvt. Ltd. v.Mr. Wazahat Choudhary
In a trademark infringement suit concerning skincare products, the Delhi High Court issued several procedural orders favoring the Plaintiff, Pureplay Skin Sciences. The court granted leave to file additional documents and exempted the plaintiff from mandatory pre-litigation mediation due to the urgency of the matter. Crucially, the court also allowed the appointment of a Local Commissioner to inspect the defendant's premises for potential counterfeit goods, while simultaneously granting exemptions regarding advance service and discovery procedures.
Sanofi - Aventis v.Controller General Of Patents, Designs and Trademarks
Sanofi - Aventis challenged an order passed by the Assistant Controller Patent and Designs, which rejected their subject invention under Sections 2(i)(j)(a) and 3(c) of the Patents Act, 1970. The Calcutta High Court took cognizance of this appeal (Oa/11/2019/Pt/Kol). While the Respondent Controller remained unrepresented, the court directed Sanofi - Aventis to ensure proper service on the Controller and file an Affidavit of Service before listing the matter for further hearing.
Sanofi SA (and related Sanofi entities) v.STADA Nordic ApS, STADA Arzneimittel AG, Accord Healthcare S.L.U., etc.
This procedural order addresses multiple infringement actions involving Sanofi and various defendants, including STADA and Accord Healthcare. The court confirmed the schedule for the final interim conference and the subsequent oral hearing, which will focus heavily on complex issues of obviousness related to clinical trial data (Phase III TROPIC study). Practitioners should note the court's proactive approach in managing expert evidence and procedural fairness across multiple related proceedings.
10x Genomics, Inc. v.Curio Bioscience Inc.
In this procedural order concerning enforcement security, the UPC Local Division in Düsseldorf ruled in favor of 10x Genomics, Inc. The Applicant had initially deposited EUR 2 million to secure a preliminary injunction but subsequently obtained and provided an equivalent bank guarantee. The Court found that the Applicant had a legitimate interest in exchanging the deposit for the bank guarantee due to logistical and economic reasons. Consequently, the Court ordered the repayment of the original security deposit.
Hilton Worldwide Manage Limited And Anr v.M/S Hilton Cloud Resort
The Delhi High Court granted an interim injunction in favor of Hilton Worldwide Manage Limited against M/S Hilton Cloud Resort, finding a prima facie case of trademark infringement and passing off. The court restrained the defendant from using the name 'HILTON CLOUD RESORT' or any confusingly similar mark while also granting four weeks to remove all listings and usage of the impugned mark across various platforms. This order sets the stage for the full trial, establishing immediate protection for the plaintiff's registered trademark.
M/S Sita Ram Iron Foundry And Engineering Works v.Hindustan Technocast (P) Ltd.
The Delhi High Court dismissed a rectification petition filed by M/S Sita Ram Iron Foundry against Hindustan Technocast regarding the trademark 'BADAL'. The petitioner alleged that the respondent's registration was obtained through fraud and fabricated documents. However, the court held that while anomalies in the respondent's documentation were noted, the petitioner failed to establish the veracity of their claims on the face of it. Consequently, the cancellation of the long-standing mark could not be granted without a thorough evidentiary test before the Trial Court.
Mohammed Azam Trading As Noor Ahmed Mohd Azam v.Paramjeet Singh & Anr.
The Delhi High Court addressed two matters: first, it condoned a minor delay in the petitioner's rectification petition. Second, the court initiated proceedings to cancel the trademark 'SARDARJI MASALE WALE NURY'. The court ordered notice to be served on all parties and directed the summoning of the complete registration record from the Trademark Registry for review.
SRF Limited v.Solvay S A & Anr.
The court passed several orders on various interlocutory applications related to the main patent dispute. Directions were given regarding the filing of additional documents, permission was granted for amending claims under Sections 58 and 59 of the Patents Act, and an application seeking amendment in a Revocation Petition was disposed of while reserving rights.
F- Hoffmann -La Roche Ag & Anr v.Zydus Lifesciences Limited
The suit was filed seeking permanent injunction against infringement of two Indian patents related to Pertuzumab (Perjeta). The plaintiffs alleged that the defendant was manufacturing and selling a competing version. However, the court found that the plaintiffs failed to conduct necessary analytical characterization or reverse engineering of the defendant's product as required under Section 104A.
Panasonic Holdings Corporation v.Xiaomi Technology Germany GmbH, Xiaomi Technology France S.A.S, Xiaomi Technology Italy S.R.L, Xiaomi Technology Netherlands B.V., Odiporo GmbH, Shamrock Mobile GmbH
This UPC decision from Mannheim concerns a case between Panasonic Holdings Corporation and various Xiaomi entities. The core of the dispute—an infringement claim alongside a revocation counterclaim—was resolved through an agreement, leading both parties to withdraw their respective claims. Although the overall outcome was a settlement, the court issued specific rulings regarding the adjustment of court fees and costs based on the increased value of the dispute.
MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. v.Zhejiang Nurotron Biotechnology Co., Ltd.
In this UPC case, MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. initiated infringement proceedings against Zhejiang Nurotron Biotechnology Co., Ltd. and Nurotron Global SARL regarding EP 4 074 373. The parties subsequently reached a settlement agreement to resolve the dispute. The Hamburg Local Division confirmed this settlement, allowing it to be treated as a final, enforceable decision while ensuring that the confidential details of the agreement remained protected in the public register.
JingAo Solar Co., Ltd. v.Chint New Energy Technology Co., Ltd.; Astronergy Europe GmbH; Astronergy GmbH; Astronergy Solarmodule GmbH; Astronergy Solar Netherlands B.V.; Chint Solar Netherlands B.V.
This UPC decision addressed a critical procedural issue regarding the synchronization of proceedings between the Unified Patent Court and the European Patent Office. The claimant successfully sought permission to amend its infringement claims, incorporating changes made during EPO opposition proceedings and introducing a newly discovered infringing product. The court emphasized that true synchronization requires the ability to translate EPO amendments into actionable claim versions within the UPC action, setting important procedural boundaries for patent litigation practitioners.
Celligence International Llc v.Deputy Controller Of Patents And Designs
Celligence International Llc filed an appeal against an order dated 30.06.2025 issued by the Deputy Controller of Patents and Designs regarding Indian patent application no. 202117058456. The court issued notice to the respondent, directing them to file a reply within four weeks.
Genevant Sciences GmbH v.Moderna, Inc.
This procedural order addressed requests from Moderna to rectify previous court orders concerning the deadlines for filing Preliminary Objections (PO). The UPC Court of First Instance found that the dates of service mentioned in the original PO Order contained clerical errors. By correcting these dates, the court confirmed that all defendants, including various international Moderna entities, had filed their preliminary objections timely and were therefore admissible to defend themselves in the main infringement proceedings.
Boehringer Ingelheim International GmbH v.Zentiva Portugal, LDA.
In a significant decision regarding generic drug competition, the UPC Court of Appeal granted provisional measures in favor of Boehringer Ingelheim against Zentiva. The court held that the completion of national health technology assessments and reimbursement procedures for generics can constitute an imminent infringement threat, even before market launch. This ruling reinforces the proactive nature of the UPC's jurisdiction across all member states, providing a strong deterrent against premature generic entry.
M/s. ARCEE Electronics v.M/s. ARCEEIKA
M/s. ARCEE Electronics filed a Commercial IP Suit alleging infringement of its registered trademark 'ARCEE' and tortious passing off against M/s. ARCEEIKA, claiming that the latter used a similar name ('ARCEEIKA') for electronic goods showrooms. The core dispute centered on territorial jurisdiction, as Defendant No. 2 challenged the court's competence to hear the matter. The Bombay High Court ultimately ruled in favor of the defendant, finding that neither the Plaintiff nor any part of the cause of action had sufficiently been demonstrated to have arisen within the court's territorial limits.
Headwater Research LLC v.Apple Inc.
In a procedural decision, the Düsseldorf Local Division of the UPC allowed both parties to withdraw their respective actions. Headwater Research LLC withdrew its infringement claim against Apple Inc., and in return, the Defendants agreed to withdraw their counterclaim seeking revocation of EP 3 107 243 B1. This case highlights how mutual agreement can lead to a swift closure of complex patent litigation proceedings within the UPC framework.
Nokia Technologies Oy v.Shanghai Sunmi Technology Co., Ltd
This UPC decision addressed an application for provisional measures (Anti-Anti-Suit Injunction) filed by Nokia against Sunmi Technology in the context of a dispute involving standard essential patents (SEPs). The court provided detailed legal guidance on when infringement is threatened and how Anti-Suit Injunctions are treated under the UPC framework. While the specific request for injunction was ultimately dismissed, the ruling offers significant clarity to practitioners regarding the threshold for provisional measures and the nature of rights violations in complex cross-border disputes.
Government Emarketplace v.Ankit Jain & Ors.
The Delhi High Court granted an urgent interim injunction in favor of Government Emarketplace (GeM), a non-profit public procurement platform. The court directed domain registrar Godaddy.com to suspend specific infringing domain names and required social media intermediary Amazon to remove links hosting unauthorized webpages. This decisive order protects the GeM trademark against online infringement, setting a strong precedent for digital rights enforcement in India.
Polidoro S.p.a. v.Bekaert Combustion Technology B.V.
In a procedural order concerning EP 2 037 175, the UPC Local Division in Mannheim granted Polidoro S.p.a. an extension of one week to file its reply brief and defense against Bekaert's counterclaim for revocation. The court acknowledged that delays in providing unredacted documents necessitated this procedural adjustment. This decision underscores the UPC's commitment to ensuring fair procedure, even when dealing with complex litigation involving both infringement claims and revocation counterclaims.
M/S Zine Davidoff S.A. v.Union Of India And Anr
The Delhi High Court ruled in favor of M/S Zine Davidoff S.A., restoring its mark 'DAVIDOFF' (No. 454875) after it had been removed by the IPAB for alleged lapse. The court found that the petitioner had renewed the mark within statutory timelines, and crucially, noted that the Trade Mark Registry failed to issue a mandatory Form O3 notice before removal. Given the Registry's admission of lacking records regarding this notice, the High Court mandated the restoration of the trademark.
Interdigital Vc Holdings Inc & Anr. v.Shenzhen Transsion Holdings Co Ltd & Ors.
The Plaintiffs filed a suit asserting infringement of their portfolio of Standard Essential Patents (SEPs) related to cellular standards (3G, 4G, 5G, HEVC) by the Defendants' mobile and smart devices. The court issued orders allowing various procedural applications, including granting liberty to amend claims for additional patents and devices, while setting timelines for pleadings and interim relief hearings.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.